by Jessica Casebolt | Feb 21, 2023 | Opioid/Substance Use Disorders, Tea Leaves
A new report from Millennium Health shows that nearly every person that tested positive for fentanyl last year also had signs of other substances, and more than 43 percent of fentanyl-positive tests were positive for up to three additional drugs, including...
by Jessica Casebolt | Feb 16, 2023 | Opioid/Substance Use Disorders, Tea Leaves
Two federal panels of addiction experts on Wednesday unanimously recommended that Narcan, the overdose-reversing nasal spray, be made widely available without a prescription, a significant step in the effort to stem skyrocketing drug fatalities. Making Narcan an...
by Jordana Choucair | Feb 13, 2023 | Opioid/Substance Use Disorders
A study published in JAMA Network Open found that insurance type plays a role in how significant the financial barriers are to medication-assisted treatment (MAT) used to treat opioid use disorder. Centers for Disease Control and Prevention (CDC) researchers found...
by Jordana Choucair | Feb 3, 2023 | Opioid/Substance Use Disorders
A bipartisan group of lawmakers urged President Biden to reinstate the Office of National Drug Control Policy’s director to a cabinet-level position to help improve the administration’s efforts addressing the overdose epidemic. The group commended Biden...
by Jordana Choucair | Jan 24, 2023 | Opioid/Substance Use Disorders
Premier Inc. released a three-part series examining the impact of Opioid Use Disorder (OUD) in the United States. The first blog found that treating OUD is costing hospitals more than $95 billion a year – just under 8 percent of all hospital expenditures. According to...
by Jordana Choucair | Jan 20, 2023 | Opioid/Substance Use Disorders
New data from the Centers for Disease Control and Prevention (CDC) found that doctors sent patients home with opioids after emergency department (ED) visits about 8 percent of the time in 2019–2020. The latest figures continue a downward trend from about 12 percent in...
Recent Comments